FindTrial
Sign In

Thai children

2 trials

Sponsors

Chengdu Institute of Biological Products, Chengdu, PR China, Queen Sirikit National Institute of Child Health

Conditions

Long term immunogenicity of CD.JEVAX as a booster does in Thai children previously vaccinated against JE with IMOJEV at least 12 months prior to the project by blood test once a year for 5 years. CD.JEVAX, IMOJEVSafety and immunogenicity of a live attenuated SA14&#45

Phase 4

Study of long term immunogenicity of a live attenuated SA14-14-2 JE Vaccine (CD.JEVAX) as a booster dose after priming with chimeric JE Vaccine (IMOJEV) in Thai children.
Active, not recruitingTCTR20221102003
Queen Sirikit National Institute of Child HealthLong term immunogenicity of CD.JEVAX as a booster does in Thai children previously vaccinated against JE with IMOJEV at least 12 months prior to the project by blood test once a year for 5 years. CD.JEVAX, IMOJEV
Start: 2016-11-06Target: 50Updated: 2026-08-03

Unknown Phase

Safety and immunogenicity of a live attenuated SA14-14-2 JE Vaccine (CD.JEVAX®) as a booster dose after priming with chimeric JE Vaccine (IMOJEV®) in Thai children
RecruitingTCTR20151213001
Chengdu Institute of Biological Products, Chengdu, PR ChinaSafety and immunogenicity of a live attenuated SA14&#45
Start: 2015-05-01Updated: 2026-08-03

Related Papers

Long-term immunogenicity of the SA14-14-2 Japanese encephalitis (JE) vaccine (CD.JEVAX®) booster following chimeric JE (IMOJEV®) vaccine priming in Thai children
Human Vaccines & Immunotherapeutics2024-10-011 citations